20.37MMarket Cap-0.24P/E (TTM)
0.738High0.700Low237.21KVolume0.720Open0.740Pre Close171.42KTurnover0.94%Turnover RatioLossP/E (Static)27.88MShares8.30052wk High-1.98P/B18.38MFloat Cap0.58052wk Low--Dividend TTM25.16MShs Float137.900Historical High--Div YieldTTM5.19%Amplitude0.580Historical Low0.722Avg Price1Lot Size
Calidi Biotherapeutics Stock Forum
Can Multiple Doses Make This Brain Cancer Treatment More Effective? Northwestern Launches Next-Phase Trial
I am still in this
Hope you bought here yesterday on my alert. If you did you might be up 40 percent and going strong.
in here
👀
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement
Tuesday, 28th January at 8:00 am
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that its ending cash balance at December 31, 2024 was approximately $9.6 million. Due to Calidi's ...
No comment yet